Customized Use of Anti-Tumour Necrosis Factor-α Therapy During Pregnancy

被引：0
作者：
Seow, Cynthia H. [1 ]
Casteele, Niels Vande [2 ]
Panaccione, Remo [1 ]
机构：
[1] Univ Calgary, Dept Med, Calgary, AB, Canada
[2] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA
来源：
JOURNAL OF CROHNS & COLITIS | 2018年 / 12卷 / 11期
关键词：
ADALIMUMAB; INFLIXIMAB;
D O I：
10.1093/ecco-jcc/jjy082
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1379 / 1380
页数：2
相关论文
共 50 条
[21]   Anti-tumour necrosis factor-α-induced lupus in a patient receiving infliximab for sarcoidosis [J].
Stranks, Lachlan ;
Chapman, Sally .
RESPIROLOGY CASE REPORTS, 2022, 10 (08)
[22]   Accumulation of plasma nucleosomes upon treatment with anti-tumour necrosis factor-α antibodies [J].
D'Auria, F ;
Rovere-Querini, P ;
Giazzon, M ;
Ajello, P ;
Baldissera, E ;
Manfredi, AA ;
Sabbadini, MG .
JOURNAL OF INTERNAL MEDICINE, 2004, 255 (03) :409-418
[23]   Withdrawal of anti-tumour necrosis factor α therapy in inflammatory bowel disease [J].
Konstantinos Papamichael ;
Severine Vermeire .
World Journal of Gastroenterology, 2015, (16) :4773-4778
[24]   Withdrawal of anti-tumour necrosis factor α therapy in inflammatory bowel disease [J].
Papamichael, Konstantinos ;
Vermeire, Severine .
WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (16) :4773-4778
[25]   Paradoxical adverse events of anti-tumour necrosis factor therapy for spondyloarthropathies: a retrospective study [J].
Fouache, Damien ;
Goeb, Vincent ;
Massy-Guillemant, Nathalie ;
Avenel, Gilles ;
Bacquet-Deschryver, Helene ;
Kozyreff-Meurice, Macha ;
Menard, Jean-Francois ;
Muraine, Marc ;
Savoye, Guillaume ;
Le Loet, Xavier ;
Tharasse, Christine ;
Vittecoq, Olivier .
RHEUMATOLOGY, 2009, 48 (07) :761-764
[26]   Effects of visceral adipose tissue on anti-tumour necrosis factor-α in Crohn's disease [J].
Li, Kangrong ;
Gong, Pan ;
Zhang, Yongbin ;
Liu, Minji ;
Zhang, Zinan ;
Yu, Xiaoyu ;
Ye, Mingmei ;
Tian, Li .
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
[27]   The Future Role of Anti-Tumour Necrosis Factor-α Products in the Treatment of Crohn's Disease [J].
Ruud A. van Hogezand ;
Hein W. Verspaget .
Drugs, 1998, 56 :299-305
[28]   Comparison of recommendations for the use of anti-tumour necrosis factor therapy in ankylosing spondylitis in 23 countries worldwide [J].
van den Berg, Rosaline ;
Stanislawska-Biernat, Ewa ;
van der Heijde, Desiree M. F. M. .
RHEUMATOLOGY, 2011, 50 (12) :2270-2277
[29]   Ocular toxoplasmosis following anti-tumour necrosis factor-α therapy combined with oral methotrexate therapy: A case report and review of literature [J].
Patnaik, Gazal ;
Pyare, Richa ;
Kaushik, V. V. ;
Dutta Majumder, Parthopratim .
EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2024, 34 (02) :NP113-NP117
[30]   Tocilizumab in JIA patients who have inadequate response to anti-tumour necrosis factor therapy [J].
R Russo ;
M Katsicas .
Pediatric Rheumatology, 9 (Suppl 1)
12345